Compounded tirzepatide and semaglutide: what the prescriber should require in quality

Demand for GLP-1 and GIP analogs has grown fast, and with it the supply of compounded versions. For the prescriber, that puts input quality and pharmacy regularity at the center of the decision. This content is informational and aimed at professionals: indication, dose and plan are exclusively the physician’s, and these products require a prescription.

Why origin matters so much

In sterile injectables, what you can’t see is what matters most. Purity, real concentration and absence of contamination don’t show on the label — they show in the report. Without a report, the prescriber takes on an invisible risk.

What to require from the pharmacy

• Regularity: current AFE, Special Authorization and sanitary license.
• Per-batch report: potency (real concentration), sterility and bacterial endotoxins.
• Input traceability: provenance and certificate of the raw material.
• Cold chain: temperature-controlled transport and on-arrival checks.

The role of a curation channel

Verifying all of this at every batch, at every pharmacy, is unfeasible in the clinic’s routine. PharmaLinker pre-qualifies licensed partner pharmacies, requires the per-batch report and organizes the injectables logistics for weight management and nutrology with a cold chain. The clinical decision stays entirely with the physician; we ensure the pharmaceutical chain is safe and traceable.

Read also

• Weight-loss injectables: safety from source to practice
• Nutrology & weight management
• Weight-loss injectables guide for clinics

Informational content for healthcare professionals. PharmaLinker is a B2B intermediation platform that connects physicians and clinics with licensed compounding-pharmacy partners (regulated by Anvisa, Brazil’s health authority); it does not sell medicines, make therapeutic claims, or replace clinical judgment. Compounded preparations require a prescription.